BioInvent International AB
STO:BINV
BioInvent International AB
Operating Income
BioInvent International AB
Operating Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
B
|
BioInvent International AB
STO:BINV
|
Operating Income
-kr471.1m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
-24%
|
|
|
Biogaia AB
STO:BIOG B
|
Operating Income
kr423.4m
|
CAGR 3-Years
20%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
|
|
Bonesupport Holding AB
STO:BONEX
|
Operating Income
kr166.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Vitrolife AB
STO:VITR
|
Operating Income
kr783m
|
CAGR 3-Years
23%
|
CAGR 5-Years
10%
|
CAGR 10-Years
19%
|
|
|
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
|
Operating Income
kr5.8B
|
CAGR 3-Years
15%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
|
BioArctic AB
STO:BIOA B
|
Operating Income
-kr228.5m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
BioInvent International AB
Glance View
BioInvent International AB engages in the research and development of novel and immuno-modulatory antibodies for the treatment of cancer. The company is headquartered in Lund, Skane and currently employs 84 full-time employees. The company went IPO on 2001-06-12. The Company’s operational activities are focused on expanding the clinical development of human antibodies, such as BI-1206, BI-1808, BI-1607 and BT-001. The firm has one wholly-owned subsidiary BioInvent Finans AB, which engaged in the administration of warrants issued by the Company.
See Also
What is BioInvent International AB's Operating Income?
Operating Income
-471.1m
SEK
Based on the financial report for Dec 31, 2024, BioInvent International AB's Operating Income amounts to -471.1m SEK.
What is BioInvent International AB's Operating Income growth rate?
Operating Income CAGR 10Y
-24%
Over the last year, the Operating Income growth was -27%. The average annual Operating Income growth rates for BioInvent International AB have been -19% over the past three years , -28% over the past five years , and -24% over the past ten years .
You don't have any saved screeners yet